Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3–17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trial

ZF2001 is a recombinant protein subunit vaccine against SARS-CoV-2 that has been approved for use in China, Colombia, Indonesia, and Uzbekistan in adults aged 18 years or older, but not yet in children and adolescents younger than 18 years. We aimed to evaluate the safety and immunogenicity of ZF200...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The lancet child & adolescent health 2023-04, Vol.7 (4), p.269-279
Hauptverfasser:	Gao, Lidong, Li, Yan, He, Peng, Chen, Zhen, Yang, Huaiyu, Li, Fangjun, Zhang, Siyuan, Wang, Danni, Wang, Guangyan, Yang, Shilong, Gong, Lihui, Ding, Fan, Ling, Mengyu, Wang, Xilu, Ci, Leilei, Dai, Lianpan, Gao, George Fu, Huang, Tao, Hu, Zhongyu, Ying, Zhifang, Sun, Jiufeng, Zuo, Xiaohu
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Antibodies, Neutralizing Antibodies, Viral Child COVID-19 - prevention & control COVID-19 Vaccines - adverse effects Humans Protein Subunits SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!